%0 Journal Article
%T Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer £¿with Brain Metastasis
%A Qi SONG
%A Shunchang JIAO
%A Fang LI
%J Öйú·Î°©ÔÓÖ¾
%D 2016
%R : 10.3779/j.issn.1009-3419.2016.08.08
%X Brain metastasis, a common complication of non-small cell lung cancer (NSCLC) with an incidence rate of 30%-50%, significantly affects the patients¡¯ quality of life. The prognosis of patients of NSCLC with brain metastasis is extremely poor, the average median survival is only 1 m-2 m without treatment. The targeted therapy based on lung cancer driven gene is a new treatment. Besides, the immunotherapy which can enhance the effect of anti-cancer by simulating the immune system is a new approach. The combination of targeted therapy and immunotherapy can greatly benefit patients in clinical work.
%K Lung neoplasms
%K Brain metastasis
%K Immunotherapy
%K Targeted therapy
%U http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2016.08.08